FOXO4-DRI 2mg

Description

CAS Number: 2460055-10-9

Disclaimer:

For research use only. Not for human consumption. Intended for laboratory-based studies by qualified professionals. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.

Overview:
FOXO4-DRI is a modified peptide sequence designed for research involving senescent cell signaling and FOXO4-p53 pathway interactions. In preclinical models, FOXO4-DRI has been explored for its potential role in selectively targeting dysfunctional senescent cells through apoptosis-related mechanisms.

Research Applications:

• Cellular senescence research
• Longevity and aging pathway studies
• p53 signaling interactions
• Senolytic compound investigations
• Tissue regeneration and recovery models

Specifications:
Form: Lyophilized powder (research-grade)
Quantity: 2mg per vial
Grade: Research Use Only
Storage: Store refrigerated (2–8°C), sealed and protected from light and moisture.

For research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.